KRAS and familial pancreatic carcinoma: In this study, we discovered the effect of KV on mediating the PI3K-Akt-mTOR and Erk-RPS6K-TMEM139 signaling pathways in oxaliplatin-resistant AsPC-1 cells (AsPC-1 cells; KRAS-mutated pancreatic cancer cells).